| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |